I'm not parent, but I'm sure this is intentional as the consequences of such a scenario are easy to extrapolate...
> The US market is where pharmaceutical companies expect to recoup their R&D costs.
They could do this in two ways - having high margins on their drugs, and/or selling a lot of drugs. It is no surprise to see pharma lobbying against tight laws on prescriptions, or anything that gets in the way of the 'market' getting access to their products. Not coincidentally, the opioid crises means they get to sell more drugs.
On the other hand in my home country we had some big pharmaceutical companies (compared to the size of the country) exporting drugs world wide. I thought that for example the pain killers I knew as I child would be used everywhere on the world. When I moved to Germany I realized that I was wrong. There are tons of different drugs for the same purpose with the same ingredients sold by different producers. Therefore only becasue you in the US buy some expensive - and highly addictive - pain killers you are not automatically financing the R&D of pain killers sold in Europe by Europian companies to the Europian people.
Let me be a smart ass and improve your calculation:
45% of drug revenue is generated by 5% of earth's population:
45% / 5% = 9
but you do not compare this number to 1 but to
55% of drug revenue is generated by 95% of earth's population:
55% / 95% = 0.58
So a US citizen spends 9 / 0.58 = 15.54 more on drugs as a non US citizen. Even if price difference is a valid argument, this number is still too high.
[1] https://www.statista.com/topics/1719/pharmaceutical-industry...